Impact of hepatitis B and C virus infection on the outcome of kidney transplantation in Chinese patients

Chinese Medical Journal (Taipei)

Volumn 63, Issue 2, 2000, Pages 93-100

  Huo, Teh Ia ^a,b   Yang, Wu Chang ^a   Wu, Jaw Ching ^a   King, Kuang Liang ^b   Loong, Che Chuan ^b   Lin, Ching Yuang ^b   Lui, Wing Yu ^b   Chang, Full Young ^a   Lee, Shou Dong ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Chronic hepatitis; Hepatitis B virus; Hepatitis C virus; Kidney transplantation

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; VIRUS DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHINESE; FEMALE; GRAFT SURVIVAL; HEPATITIS B; HEPATITIS C; HUMAN; KIDNEY TRANSPLANTATION; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; SUPERINFECTION; SURVIVAL;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED;

EID: 0033974934     PISSN: 05781337     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Starzl TE, Wei R, Iwatsuki S, Klintmalm G, Shroter GP, Koep LJ, et al. The use of cyclosporin A and prednisolone in cadaveric kidney transplantation. Surg Gynecol Obstet 1980;151:17-26.
2. Diethelm AG, Deierhoi MH, Hudson SL, Laskow DA, Julian BA, Gaston RS, et al. Progress in renal transplantation. A single center study of 3359 patients over 25 years. Ann Surg 1995;221:446-58.
3. Pol S, Debure A, Degott C, Carnot F, Legendre C, Brechot C, et al. Chronic hepatitis in kidney allograft recipients. Lancet 1990;335:878-80.
4. Mathurin P, Mouquet C, Poynard T, Sylla C, Benalia H, Fretz C, et al. Impact of hepatitis B and C virus on kidney transplantation outcome. Hepatology 1999;29: 257-63.
5. Genesca J, Vila J, Cordoba J, Sauleda S, Quer J, Esteba JI, et al. Hepatitis C virus infection in renal transplant recipients: epidemiology, clinical impact, serological confirmation and viral replication. J Hepatol 1995;22:272-7.
6. Conway M, Catterall AP, Brown EA, Tibbs C, Gower PE, Curtis JR, et al. Prevalence of antibodies to hepatitis C in dialysis patients and transplant recipients with possible routes of transmission. Nephrol Dial Transplant 1992;7: 1226-9.
7. Dusheiko G, Song E, Bowyer S, Whitcutt M, Maier G, Meyers A, Kew MC. Natural history of hepatitis B virus infection in renal transplant recipients - a fifteen-year follow-up. Hepatology 1983;3:330-6.
8. Nagington J, Cossart YE, Cohen BJ. Reactivation of hepatitis after transplantation operations. Lancet 1977;1:558-60.
9. Marcellin P, Giostra E, Martinot-Peignoux M, Loriot MA, Jaegle ML, Wolf P, et al. Redevelopment of hepatitis B surface antigen after renal transplantation. Gastroenterology 1991;100:1432-4.
10. Harnett JD, Zeldis JB, Parfrey PS, Kennedy M, Sircar R, Steinmann TI, Guttmann RD. Hepatitis B disease in dialysis and transplant patients: further epidemiologic and serologic studies. Transplantation 1987;44:369-76.
11. Parfrey PS, Forbes RDC, Hutchinson TA, Beaudoin JG, Dauphinee WD, Hollomby DJ, Gutmann RD. The clinical and pathological course of hepatitis B liver disease in renal transplant recipients. Transplantation 1984;37:461-6.
12. Parfrey PS, Farge D, Forbes RC, Dandavino R, Kenick S, Gutmann RD. Chronic hepatitis in end-stage renal disease: comparison of HBsAg-negative and HBsAg-positive patients. Kidney Int 1985;28:959-67.
13. Fornairon S, Pol S, Legendre C, Carnot F, Brechot C, Kreis H. Long term virological and pathological impact of renal transplantation on HBV chronic infection. Transplantation 1996;62:297-9.
14. Hiesse C, Buffet C, Neyrat N, Rieu P, Carpentier B, Etienne JP. Impact of HBs antigenemia on long-term patient survival and causes of death after transplantation. Clin Transplant 1992;46:461-7.
15. Pirson Y, Alexandre GPJ, Van Ypersele de Strihou C. Long-term effect of HBs antigenemia on patient survival after renal transplantation. N Engl J Med 1977;296:194-6.
16. Huang CC, Lai MK, Fong MT. Hepatitis B liver disease in cyclosporin-treated renal allograft recipients. Transplantation 1990;49:540-4.
17. Chan TM, Lok ASF, Cheng IKP. Hepatitis C in renal transplant recipients. Transplantation 1991;52:810-3.
18. Chan TM, Lok ASF, Cheng IKP, Chan RT. A prospective study of hepatitis C virus infection among renal transplant recipients. Gastroenterology 1993;104:862-8.
19. Kazi S, Prasad S, Pollak R, Holzer T, Heynen C, Fabrega AJ, et al. Hepatitis C infection in potential recipients with normal liver biochemistry does not preclude renal transplantation. Dig Dis Sci 1994;39:961-4.
20. Rhor MS, Lesniewski RR, Rubin CA, Johnson RG, Heise ER, McDonald JC, Adams PL. Risk of liver disease in HCV-seropositive kidney transplant recipients. Ann Surg 1993; 217:512-7.
21. Roth D, Zucker K, Cirocco R, DeMattos A, Burke GW, Nery J, et al. The impact of hepatitis C virus infection on renal allograft recipients. Kidney Int 1994;45:238-44.
22. Pol S, Legendre C, Saltiel C, Carnot F, Brechot C, Berthelot P, et al. Hepatitis C virus in kidney recipients: epidemiology and impact on renal transplantation J Hepatol 1992;15: 202-6.
23. Ponz E, Campistol JM, Bruguera M, Barrera JM, Gil C, Pinto JB, Andreu J. Hepatitis C virus infection among kidney transplant recipients. Kidney Int 1991;40:748-51.
24. Fritshe C, Brandes JC, Delaney SR, Gallagher-Lepak S, Memtove JE, Rich L, et al. Hepatitis C is a poor prognostic indicator in black kidney transplant recipients. Transplantation 1993;55:1283-7.
25. Solez K, Axelsen RA, Benediktsson H, Burdick JF, Cohen AH, Colvin RB, et al. International standardization of criteria for the diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993;44:411-22.
26. Huo TI, Wu JC, Lai CR, Lu CL, Sheng WY, Lee SD. Comparison of clinico-pathological features in hepatitis B virus-associated hepatocellular carcinoma with or without hepatitis D virus infection. J Hepatol 1996;25:439-44.
27. Bernuau J, Rueff B, Benhamou JP. Fulminant and subfulminant liver failure: definition and causes. Semin Liver Dis 1986;6:97-106.
28. Wu JC, Chen CL, Hou MC, Chen TZ, Lee SD, Lo KJ. Multiple virus infection as the most common cause of fulminant and subfulminant viral hepatitis in an area endemic for hepatitis B: application and limitation of the polymerase chain reaction. Hepatology 1993;19: 836-40.
29. Huang CC. Hepatitis in patients with end-stage renal disease. J Gastroenterol Hepatol 1997;12:S236-41.
30. Fairley CK, Mijch A, Gust ID, Nichilson S, Dimitrakakis M, Lukas CR. The increased risk of fatal liver disease in renal transplant patients who are hepatitis B antigen and/or HBV DNA positive. Transplantation 1991;52: 497-500.
31. Degos F, Lugassy C, Degott C, Debure A, Camot F, Theirs V, et al. Hepatitis B virus and hepatitis B-related viral infection in renal transplant recipients: a prospective study of 90 patients. Gastroenterology 1988;94:151-6.
32. Huang CC. Dialysis therapy in Taiwan: 1995 National Surveillance Report. J Nephrol ROC 1995;9:71-83.
33. Lee SD, Chan CY, Wang YJ, Wu JC, Lai KH, Tsai YT, Lo KW. Seroepidemiology of hepatitis C virus infection in Taiwan. Hepatology 1991;13:830-3.
34. Pereira BJG, Levey AS. Hepatitis C virus infection in dialysis and renal transplantation. Kidney Int 1997;51: 981-99.
35. Beasley RP, Huang LY. Postnatal infectivity of hepatitis B surface antigen-carrier mothers. J Infect Dis 1983;147: 185-90.
36. Beasley RP, Hwang LY, Lin CC, Leu ML, Stevens CE, Szmuness W, Chen KP. Incidence of hepatitis B virus infections in preschool children in Taiwan. J Infect Dis 1982;146:198-204.
37. London WT, Drew JS, Blumberg BS, Grossman RA, Lyons PJ. Association of graft survival with host response to hepatitis B infection in patients with kidney transplants. N Engl J Med 1977;296:241-4.
38. Dienstag JL. Renal transplantation and hepatitis B. Gastroenterology 1988;94:235-8.
39. Orloff SL, Stempel CA, Wright TL, et al. Long-term outcome in kidney transplant patients with hepatitis C virus (HCV) infection. Clin Transplant 1995;9:119-24.
40. Ynares C, Johnson HK, Kerlin T, Crowe D, MacDonnell R, Richie R. Impact of pretransplant hepatitis C antibody status upon long-term patient and renal allograft survival: a 5- and 10-year follow-up. Transplant Proc 1993;25: 1466-8.
41. Legendre C, Garrigue V, Le Bihan C, Mamzer-Bruneel MF, Chaix ML, Landais P, et al. Harmful long-term impact of hepatitis C virus infection in kidney transplant recipients. Transplantation 1998;65:667-70.
42. Liaw YF. Role of hepatitis C virus in dual and triple hepatitis virus infection. Hepatology 1995;22:1101-8.
43. Koike K, Yasuda K, Yotsuyanagi H, Moriya K, Hino K, Kurokawa K, Iino S. Dominant replication of either virus in dual infection with hepatitis viruses B and C. J Med Virol 1995;45:236-9.
44. Pontisso P, Ruvoletto MG, Fattovich G, Chemello L, Gallorini A, Ruol A, Alberti A. Clinical and virological profiles in patients with multiple hepatitis virus infections. Gastroenterology 1993;105:1529-33.